Erratum: Understanding Rare Adverse Outcomes Following Living Kidney Donation JAMA - Journal of the American Medical Association (2014;311[6]:577-578. doi:10.1001/jama.2013.285142);Understanding rare adverse outcomes following living kidney donation

JAMA

Volumn 311, Issue 6, 2014, Pages 577-578

  Gill, John S ^a,b   Tonelli, Marcello ^c,d,e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d UNIVERSITY OF ALBERTA   (Canada)

^e Interdisciplinary Chronic Disease Collaboration   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADVERSE OUTCOME; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DEATH; DIALYSIS; DISEASE COURSE; EDITORIAL; ELECTIVE SURGERY; END STAGE RENAL DISEASE; HEALTH CARE POLICY; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LIVING DONOR; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; SIBLING; TREATMENT DURATION;

EID: 84893670738     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2014.7590     Document Type: Erratum

References (14)

1. Murray JE. Ronald Lee Herrick Memorial: June 15, 1931-December 27, 2010. Am J Transplant. 2011;11(3):419.
2. Tonelli M, Wiebe N, Knoll G, et al. Kidney transplantation compared with dialysis in clinically relevant outcomes. Am J Transplant. 2011;11(10):2093- 2109.
3. World Health Organization. Global observatory on donation and transplantation. www.who.int/transplantation/knowledgebase/en. Accessed January 2, 2014.
4. Williams SL, Oler J, Jorkasky DK. Long-term renal function in kidney donors. Ann Intern Med. 1986;105(1):1-8.
5. Najarian JS, Chavers BM, McHugh LE, Matas AJ. 20 years or more of follow-up of living kidney donors. Lancet. 1992;340(8823):807-810.
6. Fehrman-Ekholm I, Elinder CG, Stenbeck M, Tydén G, Groth CG. Kidney donors live longer. Transplantation. 1997;64(7):976-978. (Pubitemid 27446761)
7. Muzaale AD, Massie AB, Wang M-C, et al. Risk of end-stage renal disease following live kidney donation. JAMA. doi:10.1001/jama.2013.285141.
8. Segev DL, Muzaale AD, Caffo BS, et al. Perioperative mortality and long-term survival following live kidney donation. JAMA. 2010;303(10):959-966.
9. Foley RN, Murray AM, Li S, et al. Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999. J Am Soc Nephrol. 2005;16(2):489-495. (Pubitemid 41725146)
10. Garg AX, Meirambayeva A, Huang A, et al. Cardiovascular disease in kidney donors: matched cohort study. BMJ. 2012;344(344):e1203.
11. Ellison MD, McBride MA, Taranto SE, Delmonico FL, Kauffman HM. Living kidney donors in need of kidney transplants. Transplantation. 2002;74(9):1349-1351.
12. Mjøen G, Hallan S, Hartmann A, et al. Long-term risks for kidney donors. Kidney Int. 2013;27(10):460.
13. Malenka DJ, Baron JA, Johansen S, Wahrenberger JW, Ross JM. The framing effect of relative and absolute risk. J Gen Intern Med. 1993;8(10):543-548. (Pubitemid 23312931)
14. O'Connor AM, Bennett CL, Stacey D, et al. Decision aids for people facing health treatment or screening decisions. Cochrane Database Syst Rev. 2009;8(3):CD001431.